logo for SONN

SONN • NASDAQ

Sonnet BioTherapeutics Holdings, Inc.

$1.26

+ Add to Watchlist

Stock Details

Market Cap 8,434,046
Day Change -1.84 (-59.35%)
Volume 10,428,964
Avg Volume 1,129,433
Price Range

Overview

Country US
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ

Company Profile

Sonnet BioTherapeutics Holdings, Inc., a biotechnology company based in Princeton, New Jersey, operates in the clinical stage with a primary focus on oncology. The firm is dedicated to developing novel platforms for creating biologic medicines that can exhibit either singular or dual therapeutic mechanisms. Central to their strategy is a proprietary fully human albumin binding technology. This innovative system employs human single-chain antibody fragments specifically engineered to bind to human serum albumin, leveraging it for enhanced delivery and transport to target tissues. Their leading therapeutic candidate, SON-1010, is a fully human variant of interleukin 12, currently being advanced for the treatment of non-small cell lung cancer and cancers affecting the head and neck. Additionally, Sonnet is progressing SON-080, another fully human interleukin 6 formulation, intended to address both chemotherapy-induced and diabetic peripheral neuropathy. The company also maintains a licensing agreement with New Life Therapeutics PTE, LTD., for the development and commercialization of pharmaceutical preparations containing a specific recombinant human interleukin 6.

Financial Overview

52 Week High 5.95
52 Week High Date 2025-11-17
52 Week Low 1.26
52 Week Low Date 2025-12-02
10D Avg Trading Vol 1.70668
YTD Price Return Daily -76.4486
MTD Price Return Daily -66.129

Cash Flow

TTM/Share -34.70324
Annual/Share -13.2554
Quarterly/Share -3.0974

Price-to-Earnings

Annual Ratio 0.6598
Quarterly Ratio 0.2586
TTM

Revenue

3Y Growth -66.14
5Y Growth -77.27
Annual/Share
TTM/Share 0.2522
5Y Share Growth

Earnings Per Share

Annual -11.3504
3Y Growth
5Y Growth
Quarterly YOY Growth

Price-to-Book

Ratio 13.4662
Annual Ratio 1.5831
TTM 6.2031